Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate tolerability and effectiveness of conventional
treatment for mild to moderate arthritic or arthralgic symptoms while subjects are being
treated with efalizumab for psoriasis.